Dr. Sulaiman Al-habib Medical Services Group Co. · TADAWUL:4013
Dr. Sulaiman Al-habib Medical Services — FY2023 Earnings Presentation
38 slides from Dr. Sulaiman Al-habib Medical Services's earnings presentation, February 2024
Slide 1: FY 2023 Investor Presentation
FY 2023 Investor Presentation As of February 2024
Slide 2: Disclaimer
DISCLAIMER Disclaimer and important information in relation to this presentation This presentation is for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investm
Slide 3: Presenting Team
PRESENTING TEAM Faisal Al Nassar Ziyad Al Dahami Chief Executive Officer Head of Treasury and Investor Relations FY 2023 Investor Presentation 3 February 2024
Slide 4: Agenda
AGENDA Financial Performance Project Update Operational Highlights Appendix #1 Summarized Financials Appendix #2 About HMG
Slide 5: Financial Performance
us! ULoatin.s DR SULAIMAN AL HABIB medical group auiJlacgo3oll Financial Performance
Slide 6: Key Financial Highlights: FY 2023
KEY FINANCIAL HIGHLIGHTS : FY 2023 Revenue by segment SAR million +14.41% Gross profit 18.99% Gross profit Margin FY 2023 3,270.05 FY 2023 34.39% FY 2022 FY 2023 FY 2022 2,748.14 FY 2022 33.07% SAR (Millions) 288.94 198.67 3.48% 2.08% 1,724.04 1,991.57 20.74% 20.95% EBITDA 18.49% EBITDA margin 8,310
Slide 7: Balance Sheet Highlight
BALANCE SHEET HIGHLIGHT FY 2022 FY 2023 Total assets Total assets SAR 12.58 billion SAR 15.80 billion ROE ROA FY 2023 33.10% FY 2023 14.42% Cash, time 16.59% Current deposit & bank 21.83% 20.58% 20.88% FY 2022 29.43% FY 2022 14.10% liabilities balances Accounts 4.45% receivable 5.89% 3.44% 1.71% Non
Slide 8: Low Leverage Levels
LOW LEVERAGE LEVELS Total liabilities and equity SAR million 120.00% Total Liabilities/Total Assets Total Liabilities/Equity FY 2023 0.57x FY 2023 1.33x 100.00% FY 2022 0.51x FY 2022 1.06x 80.00% 42.83% 6,105.66 48.52% 6,766.25 Debt / Equity Net Debt / EBITDA 60.00% FY 2023 0.77x FY 2023 1.04x FY 20
Slide 9: Total Cash Dividends for Shareholders
TOTAL CASH DIVIDENDS FOR SHAREHOLDERS Declared dividends Declared Cash dividends / Q4 2023 0 50 100 150 200 250 300 350 400 450 Total distributed dividends SAR 402.50 million Q4 2023 SAR 1.15 per share SR 402.5mn 76.7% Payout Q3 2023 SAR 1.17 per share SR 409.5mn 75.2% Payout % of capital 11.50% (eq
Slide 10: Highlights: 2023 Patient Overview
HIGHLIGHTS: 2023 PATIENT OVERVIEW Patient overview Revenue by type 73.3% 69.0% +6 m 2022 2023 Patients served 24.8% 22.4% From +5.3 m in 2022 4.1% 2.3% 2.1% 2.0% Insurance Cash Government Others Bed occupancy - overall Bed occupancy - ICU 80% 82% FY 2023 Investor Presentation 10 February 2024
Slide 11: Projects Update
Projects Update FY 2023 Investor Presentation 11 February 2024
Slide 12: Projects Update
PROJECTS UPDATE Solidifying our market leadership through a robust expansion plans and progressing our projects South-West Jeddah Hospital North Riyadh Hospital Expansion of Qassim Hospital 50% 2024 100% 2024 100% 2024 Ownership Expected Ownership Expected Ownership Expected completion completion co
Slide 13: Projects Update
PROJECTS UPDATE Solidifying our market leadership through a robust expansion plans and progressing our projects Maternity and Pediatric Hospital Buraidah Medical Center North Jeddah Hospital (New Takhassusi Expansion) 2024 2024 2024 100% 100% 100% Expected Expected Expected Ownership Ownership Owner
Slide 14: Projects Update
PROJECTS UPDATE Solidifying our market leadership through a robust expansion plans and progressing our projects Sehat Al Kharj Hospital Hamra Hospital Tabuk Hospital Madinah Hospital 2024 2025 Land 2027 Land 100% 100% 50 Expected Expected Leased Expected Leased Ownership Ownership Years completion c
Slide 15: Operational Highlights
u4i14I5!yuLgitiu.s DR SULAIMAN AL HABIB medical group auhiiac9.o2.0/) Operational Highlights
Slide 16: FY 2023 Highlights
FY 2023 HIGHLIGHTS Key Highlights HMG Mobile Application Launched three medical centers in Riyadh: Digital City, Narjis and Ghadeer. Interaction 10% Announced to establish the 140 beds Hospital in Tabuk city at an estimate total cost of SAR 420 million. +551.8 m Signed conditional investment agreeme
Slide 17: Recognitions & Accreditations
FY 2023 HIGHLIGHTS RECOGNITIONS & ACCREDITATIONS HMG continues to receive recognitions and accreditations from organizations around the world in recognition of our service quality and standards. EFQM Level-4 certification of Patient Safety Friendly Hospital Framework (PSFH) FY 2023 Investor Presenta
Slide 18: Medical Excellence
FY 2023 HIGHLIGHTS MEDICAL EXCELLENCE Creating the medical practitioners of the future and promoting health and well-being Research Center Continuous Medical Education Postgraduate Program 4 Journals issued 230+ Activities 500+ Hours 30+ 20+ Research papers published in Dr. Residency & Fellowshi
Slide 19: Our People
FY 2023 HIGHLIGHTS OUR PEOPLE Continued to attract and retain top talent in the Kingdom People Physicians 17,500+ 58% female +39% 3,900+ +90% 15+ average years Employees 42% male Saudization Physicians Retention Rate Experience Staff ratio Physician Qualifications 80+ 120+ recruiting Nationalities o
Slide 20: ESG & Sustainability
FY 2023 HIGHLIGHTS ESG & SUSTAINABILITY The Group’s ESG structures and targets aim to maximize the benefits we deliver in terms of patient health, the broader contexts of social and human development, and responsible environmental stewardship ESG Roadmap CSR Activities HMG is undertaking a four-phas
Slide 21: Appendix #1: Summarized Financials
Appendix #1 Summarized Financials
Slide 22: Summary: Balance Sheet
SUMMARY: BALANCE SHEET As of 31 December 2023 SAR million FY 2023 FY 2022 Current Assets 4,137.83 4,160.48 Investment in Associates 197.59 187.00 Investments in equity instruments – Sukuk 300.00 300.00 Property and Equipment 11,162.62 7,936.64 Total Assets 15,798.04 12,584.12 Current Liabilities 3,2
Slide 23: Summary: Income Statement
SUMMARY: INCOME STATEMENT As of 31 December 2023 SAR million FY 2023 FY 2022 Change % Revenue 9,508.44 8,310.74 14.41% Cost of revenue (6,238.39) (5,562.60) 12.15% Gross profit 3,270.05 2,748.14 18.99% Selling and marketing expenses (402.70) (324.78) 23.99% General and administrative expenses (771.7
Slide 24: Summary: Cash Flow Statement
SUMMARY: CASH FLOW STATEMENT As of 31 December 2023 SAR million FY 2023 FY 2022 Net cash from operating activities 3,244.15 2,843.68 Net cash used in investing activities (3,486.63) (1,939.40) Net cash from (used in) financing activities 115.87 (801.12) Cash and cash equivalents at the beginning of
Slide 25: Appendix #2: About HMG
us! Uloatin.s DR SULAIMAN AL HABIB medical group auhJlacgololl Appendix #2
Slide 26: A Fully Integrated Healthcare Services Provider
A FULLY INTEGRATED HEALTHCARE SERVICES PROVIDER Dr. Sulaiman Al Habib Medical Services Group Company (HMG) is a diversified healthcare 25 60+ leader in the Middle East, recognized for Medical Facilities Sub-specialties comprehensive healthcare services, forward- thinking innovation and the superior
Slide 27: Where We Operate
WHERE WE OPERATE With total built-up area of 689,000+ m2, HMG owns most of its hospital properties Tabuk Hospital Neom KINGDOM OF SAUDI ARABIA Kingdom of Hospital under construction Bahrain Dammam Medical Center Qassim Khobar Madinah Dubai Riyadh Medical Center under construction KAEC UAE Kharj Oper
Slide 28: Our Strategy
OUR STRATEGY Our well-defined growth strategy enhanced by our core values Our Value Our Pillar Our Priorities Strengthening our core Integrity & Attract & Invest Excellence Drivers: Human capital, cutting-edge technology and and Quality Provide integrated Maintain position as Trust in the best opera
Slide 29: Key Message
KEY MESSAGE Strategic pillars underpin our drive to deliver best-in-class healthcare services Best-in-class Catalysts for value creation Efficiency drivers • Regional integrated healthcare • Technology: Pioneer in healthcare • Efficient cash conversion cycle: provider with 25+ year track record tech
Slide 30: Business Structure
BUSINESS STRUCTURE A fully integrated healthcare services provider HOSPITALS & PHARMACIES HMG SOLUTIONS HEALTHCARE FACILITIES Cloud Providing leading-edge technological 25 Medical Facilities Outpatient pharmacies as part of Solutions solutions to boost healthcare quality and the hospitals patient ex
Slide 31: Business Model
BUSINESS MODEL Through our vertically integrated business model, we are committed to create sustainable value for our stakeholders OUR KEY STRENGTHS WHAT WE DO HOW WE MAXIMISE VALUE Cutting-edge Technology Patient-centric approach Facilities and services Leading Brand in Prime Locations Continuum of
Slide 32: Our Story
OUR STORY 1995 2007 2008 2009 Olaya Medical Dubai Medical Center Maternity Hospital Qassim Hospital Complex 2013 2012 2011 2010 MD Lab Takhassusi Hospital Home Healthcare Rayan Hospital Cloud Solutions University Medical Bone, Joint & Center in Bahrain Spinal Hospital 2015 2016 2017 2019
Slide 33: Medical Excellence
MEDICAL EXCELLENCE Medical Operation Strategic Pillars Performance & Efficiency HMG significantly reduced the admission waiting time for our patients and ensured their timely discharge from our hospitals. Patient Safety HMG artificial heart and lung program is one of many sophisticated services that
Slide 34: Pioneer in Healthcare Technology
PIONEER IN HEALTHCARE TECHNOLOGY Better medical outcomes, exceptional patient experience, and advanced operational practices Tele-medicine HIS (VIDA) Developing cutting edge technology Tele-Cardiology (Nabad 24 program) Pioneer in healthcare technology, award-winning hospital information system (HIS
Slide 35: Diverse Board of Directors
DIVERSE BOARD OF DIRECTORS Our success is driven by our people 3 NON-EXECUTIVES 2 EXECUTIVES 3 INDEPENDENTS Mr. Faisal Al Nassar Dr. Sulaiman Al Habib Mr. Obaid Al Rasheed Board Member, Chairman Board Member CEO Mr. Hesham Al Habib Mr. Mazen Al Rumaih Board Member and Chief Dr. Abdulrahman Al Taraig
Slide 36: HMG's Committees
HMG’s COMMITTEES Our success is driven by our people NOMINATION & PATIENT SAFETY & AUDIT RENUMERATION EXECUTIVE QUALITY OF CARE COMMITTEE COMMITTEE COMMITTEE COMMITTEE Dr. Abdulrahman Al Turaigi Mr. Obaid Al Rasheed Mr. Mazen Al Rumaih Prof. Mahmoud Al Ahwal Chairman Chairman Chairman Chairman Mr. R
Slide 37: Experienced Senior Management
EXPERIENCED SENIOR MANAGEMENT Highly experienced, high caliber management Mr. Faisal Al Nassar CEO CORE FUNCTIONS CORPORATE FUNCTIONS INDEPENDENT FUNCTIONS Dr. Abdulwahab Ms. Emmeline Eng. Abdullah Dr. Riyad Al Atiqi Mr. Hesham Al Habib Al Abdulwahab Chief Business Roodenburg Al Sudais General Direc
Slide 38: Thank you
Thank you Dr. Sulaiman Al Habib Medical Services Group Tel: +966 11 525 9999 Ext# 4919 Mobile: +966 50 338 2785 Email: investor.relations@drsulaimanalhabib.com Website: www.hmg.com
Dr. Sulaiman Al Habib Medical Services Group — FY2023 Earnings Presentation on 6ix